S. Korea's Celltrion says top shareholder drops plan to sell stake

SEOUL, July 2 Wed Jul 2, 2014 3:23am EDT

Related Topics

SEOUL, July 2 (Reuters) - Celltrion Inc said on Wednesday its top shareholder is no longer considering a sale of a stake in the biotechnology company.

Founder and Chief Executive Seo Jung-jin last year said he would seek a buyer among multinational drugmakers for his controlling interest in the company.

Celltrion is the largest stock on South Korea's junior bourse with a market value of 4.87 trillion won ($4.83 billion) as of Wednesday's close.

($1 = 1009.1000 South Korean Won) (Reporting by Joyce Lee; Editing by Christopher Cushing)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.